American National Insurance’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | $753K | Sell |
5,500
-410
| -7% | -$57.1K | 0.2% | 142 |
|
|
2021
Q4 | $1.02M | Sell |
5,910
-4,867
| -45% | -$741K | 0.23% | 128 |
|
|
2021
Q3 | $1.57M | Sell |
10,777
-15
| -0.1% | -$2.19K | 0.06% | 227 |
|
|
2021
Q2 | $1.42M | Sell |
10,792
-25
| -0.2% | -$3.27K | 0.05% | 235 |
|
|
2021
Q1 | $1.39M | Sell |
10,817
-33
| -0.3% | -$4.07K | 0.06% | 231 |
|
|
2020
Q4 | $1.29M | Hold |
10,850
| – | – | 0.06% | 222 |
|
|
2020
Q3 | $1.24M | Hold |
10,850
| – | – | 0.06% | 206 |
|
|
2020
Q2 | $1.24M | Hold |
10,850
| – | – | 0.06% | 206 |
|
|
2020
Q1 | $871K | Hold |
10,850
| – | – | 0.06% | 203 |
|
|
2019
Q4 | $1.16M | Hold |
10,850
| – | – | 0.06% | 209 |
|
|
2019
Q3 | $1.16M | Hold |
10,850
| – | – | 0.06% | 209 |
|
|
2019
Q2 | $1.1M | Hold |
10,850
| – | – | 0.06% | 211 |
|
|
2019
Q1 | $976K | Hold |
10,850
| – | – | 0.05% | 219 |
|
|
2018
Q4 | $903K | Hold |
10,850
| – | – | 0.05% | 215 |
|
|
2018
Q3 | $1.17M | Hold |
10,850
| – | – | 0.06% | 210 |
|
|
2018
Q2 | $1.19M | Hold |
10,850
| – | – | 0.06% | 243 |
|
|
2018
Q1 | $1.09M | Hold |
10,850
| – | – | 0.06% | 245 |
|
|
2017
Q4 | $1.07M | Hold |
10,850
| – | – | 0.05% | 251 |
|
|
2017
Q3 | $1.02M | Hold |
10,850
| – | – | 0.05% | 252 |
|
|
2017
Q2 | $1.21M | Hold |
10,850
| – | – | 0.07% | 229 |
|
|
2017
Q1 | $1.06M | Hold |
10,850
| – | – | 0.06% | 239 |
|
|
2016
Q4 | $997K | Hold |
10,850
| – | – | 0.06% | 237 |
|
|
2016
Q3 | $918K | Hold |
10,850
| – | – | 0.05% | 258 |
|
|
2016
Q2 | $883K | Hold |
10,850
| – | – | 0.05% | 261 |
|
|
2016
Q1 | $775K | Sell |
10,850
-50
| -0.5% | -$3.35K | 0.05% | 274 |
|
|
2015
Q4 | $775K | Hold |
10,900
| – | – | 0.05% | 278 |
|
|
2015
Q3 | $670K | Hold |
10,900
| – | – | 0.04% | 278 |
|
|
2015
Q2 | $790K | Hold |
10,900
| – | – | 0.05% | 266 |
|
|
2015
Q1 | $838K | Hold |
10,900
| – | – | 0.05% | 261 |
|
|
2014
Q4 | $731K | Hold |
10,900
| – | – | 0.04% | 273 |
|
|
2014
Q3 | $661K | Hold |
10,900
| – | – | 0.04% | 282 |
|
|
2014
Q2 | $640K | Hold |
10,900
| – | – | 0.04% | 287 |
|
|
2014
Q1 | $631K | Hold |
10,900
| – | – | 0.04% | 280 |
|
|
2013
Q4 | $584K | Hold |
10,900
| – | – | 0.04% | 290 |
|
|
2013
Q3 | $674K | Sell |
10,900
-3,500
| -24% | -$209K | 0.05% | 267 |
|
|
2013
Q2 | $873K | Buy |
+14,400
| New | +$858K | 0.07% | 243 |
|
Other funds holding DGX
DSA
American National Insurance's DGX Position: Q1 2022 in Review
American National Insurance reduced its Quest Diagnostics (DGX) stake by 6.9% in Q1 2022, selling an estimated $57.1K and leaving 5,500 shares worth $753K. The position accounts for 0.2% of the portfolio, ranked #142.
American National Insurance first reported a position in DGX in Q2 2013 and has held it in 36 quarters since. The position peaked at $1.57M in Q3 2021. 851 funds tracked by Wall St. Rank hold DGX as of Q1 2022.
- American National Insurance held 5,500 shares of Quest Diagnostics worth $753K as of Q1 2022.
- American National Insurance sold 410 Quest Diagnostics shares in Q1 2022, an estimated $57.1K.
- Quest Diagnostics made up 0.2% of American National Insurance's portfolio in Q1 2022, its #142 holding.
- American National Insurance first reported a position in Quest Diagnostics in Q2 2013 and has held it in 36 quarters since.
- American National Insurance's Quest Diagnostics position peaked at $1.57M in Q3 2021.
- 851 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2022.
Based on American National Insurance's 13F filing for Q1 2022, filed 13 May 2022.